Ontario Teachers Pension Plan Board Raises Holdings in Henry Schein, Inc. (HSIC)
Ontario Teachers Pension Plan Board raised its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 26.7% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 45,521 shares of the company’s stock after buying an additional 9,580 shares during the period. Ontario Teachers Pension Plan Board owned about 0.06% of Henry Schein worth $8,331,000 as of its most recent SEC filing.
Several other large investors also recently modified their holdings of HSIC. Lee Financial Co acquired a new stake in shares of Henry Schein during the 2nd quarter valued at $161,000. Westside Investment Management Inc. acquired a new stake in shares of Henry Schein during the 1st quarter valued at $168,000. JNBA Financial Advisors acquired a new stake in shares of Henry Schein during the 1st quarter valued at $170,000. Acrospire Investment Management LLC boosted its stake in shares of Henry Schein by 150.0% during the 2nd quarter. Acrospire Investment Management LLC now owns 1,000 shares of the company’s stock valued at $183,000 after buying an additional 600 shares during the period. Finally, Van ECK Associates Corp boosted its stake in shares of Henry Schein by 5.7% during the 1st quarter. Van ECK Associates Corp now owns 1,138 shares of the company’s stock valued at $193,000 after buying an additional 61 shares during the period. 44.52% of the stock is owned by institutional investors.
TRADEMARK VIOLATION NOTICE: “Ontario Teachers Pension Plan Board Raises Holdings in Henry Schein, Inc. (HSIC)” was posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another website, it was illegally stolen and republished in violation of U.S. and international trademark and copyright law. The correct version of this piece can be read at https://www.thecerbatgem.com/2017/09/28/ontario-teachers-pension-plan-board-raises-holdings-in-henry-schein-inc-hsic.html.
In related news, SVP Paul Rose sold 2,126 shares of the stock in a transaction on Wednesday, September 6th. The shares were sold at an average price of $172.51, for a total transaction of $366,756.26. Following the completion of the transaction, the senior vice president now owns 17,841 shares in the company, valued at $3,077,750.91. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 1.27% of the company’s stock.
Henry Schein, Inc. (NASDAQ:HSIC) opened at 80.59 on Thursday. The company has a market cap of $12.74 billion, a P/E ratio of 23.55 and a beta of 1.10. Henry Schein, Inc. has a one year low of $73.11 and a one year high of $93.50. The company has a 50-day moving average of $85.78 and a 200 day moving average of $88.02.
Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, August 8th. The company reported $0.88 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.86 by $0.02. Henry Schein had a net margin of 4.59% and a return on equity of 19.91%. The business had revenue of $3.06 billion during the quarter, compared to analysts’ expectations of $3.05 billion. During the same quarter in the prior year, the company posted $0.82 earnings per share. The firm’s revenue was up 6.4% on a year-over-year basis. Equities research analysts predict that Henry Schein, Inc. will post $3.64 EPS for the current year.
Henry Schein announced that its Board of Directors has approved a share repurchase plan on Monday, September 18th that permits the company to repurchase $400.00 million in shares. This repurchase authorization permits the company to buy up to 6.3% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company’s board of directors believes its stock is undervalued.
HSIC has been the subject of a number of research reports. Credit Suisse Group reissued a “hold” rating and set a $87.50 target price on shares of Henry Schein in a research note on Tuesday, August 29th. Zacks Investment Research lowered shares of Henry Schein from a “buy” rating to a “hold” rating in a research note on Friday, June 23rd. Piper Jaffray Companies raised shares of Henry Schein from a “neutral” rating to an “overweight” rating in a research note on Friday, September 15th. Stifel Nicolaus reissued a “hold” rating on shares of Henry Schein in a research note on Thursday, July 6th. Finally, Jefferies Group LLC reissued a “hold” rating and set a $88.50 target price on shares of Henry Schein in a research note on Friday, July 21st. One analyst has rated the stock with a sell rating, eleven have assigned a hold rating and seven have given a buy rating to the company’s stock. Henry Schein currently has an average rating of “Hold” and a consensus target price of $92.85.
Henry Schein Company Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Stock Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related stocks with our FREE daily email newsletter.